1. Bioinformatic analysis of the S protein of human respiratory coronavirus.
- Author
-
Niu, Zheng, Xu, ShaSha, Zhang, JingYi, Zou, ZhuoLan, Ren, LiXin, Liu, XiangYang, Zhang, ShuJuan, Zou, Hong, Hu, Xia, Wang, Jing, Zhang, Li, Zhou, Yang, and Song, ZhenHui
- Subjects
- *
MERS coronavirus , *CELL receptors , *CORONAVIRUSES , *PROTEIN analysis , *COVID-19 - Abstract
[Display omitted] • Human respiratory coronaviruses threaten human health. • Human respiratory coronaviruses infect cells via the S protein. • Despite in-depth experiments, there are lack of studies on their fundamental properties. • Understanding their basic properties could aid the fight against SARS-CoV-2 infection. The present study aimed to apply bioinformatic methods to analyze the structure of the S protein of human respiratory coronaviruses, including severe respiratory disease syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), human coronavirus HKU1 (HCoV-HKU1), and severe respiratory disease syndrome coronavirus type 2 (SARS-CoV-2). We predicted and analyzed the physicochemical properties, hydrophilicity and hydrophobicity, transmembrane regions, signal peptides, phosphorylation and glycosylation sites, epitopes, functional domains, and motifs of the S proteins of human respiratory coronaviruses. All four S proteins contain a transmembrane region, which enables them to bind to host cell surface receptors. All four S proteins contain a signal peptide, phosphorylation sites, glycosylation sites, and epitopes. The predicted phosphorylation sites might mediate S protein activation, the glycosylation sites might affect the cellular orientation of the virus, and the predicted epitopes might have implications for the design of antiviral inhibitors. The S proteins of all four viruses have two structural domains, S1 (C-terminal and N-terminal domains) and S2 (homology region 1 and 2). Our bioinformatic analysis of the structural and functional domains of human respiratory coronavirus S proteins provides a basis for future research to develop broad-spectrum antiviral drugs, vaccines, and antibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF